Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
No significant differences were noted in sex distribution, comorbidities (hypertension, diabetes), or other laboratory parameters (lipid profile, GFR, 25‐hydroxyvitamin D; p > 0.05).
Source: Demographic and Clinical Characteristics of Participants. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cross-sectional study.
Cross-sectional study
Examines a population at a particular point in time.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
In this cross‐sectional study, 243 patients with PD and 90 age‐ and sex‐matched healthy controls (HCs) were enrolled.
Source: Abstract.
Based on motor symptoms, PD patients were further divided into three subtypes: tremor‐dominant (TD), postural instability and gait disorder (PIGD), and indeterminate subtype (IND).
Source: Abstract.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Correlation Between Cognitive Function and Serum Irisin Levels in Parkinson's Disease Patients
Cross-sectional study · Brain and Behavior · 2026
Original publication title
Correlation Between Cognitive Function and Serum Irisin Levels in Parkinson's Disease Patients
© 2026 The Author(s). Brain and Behavior published by Wiley Periodicals LLC.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Cognitive impairment is a common non‐motor symptom of Parkinson's disease (PD) that markedly reduces patients’ quality of life. Given the clinical heterogeneity of PD‐related cognitive impairment (PDCI), further clarification of clinical and circulating biological factors associated with cognitive status may help improve our understanding of cognitive dysfunction in PD.
Source: IntroductionAbstract: What methods does the paper describe?
In this cross‐sectional study, 243 patients with PD and 90 age‐ and sex‐matched healthy controls (HCs) were enrolled. Cognitive function was evaluated using the Montreal Cognitive Assessment (MoCA), and patients with PD were classified into the PD with cognitive impairment (PDCI) and PD without cognitive impairment (PDNCI) groups. Based on motor symptoms, PD patients were further divided into three subtypes: tremor‐dominant (TD), postural instability and gait disorder (PIGD), and indeterminate subtype (IND). Group comparisons and logistic regression analyses were performed to examine factors associated with cognitive impairment.
Source: MethodsAbstract: Results
Serum irisin levels did not differ significantly between patients with PD and healthy controls (p = 0.478). Compared with PDNCI patients, those with PDCI had lower serum irisin levels. Among motor subtypes, the PIGD group showed a higher prevalence of cognitive impairment (68.8% vs. 46.2%, p < 0.001) and significantly lower irisin levels compared with the TD group [3.25 (2.62 to 4.14) vs. 4.12 (3.42 to 5.07) µg/mL, p < 0.001]. Serum irisin levels were weakly but positively associated with memory performance, and this association remained significant after FDR correction across the five cognitive domains (r = 0.194, FDR‐adjusted p = 0.010).
Compared with patients in the TD: high irisin group, those in the PIGD: low irisin group had higher odds of concurrent cognitive impairment (OR = 6.065, 95% CI: 2.974 to 18.638, p = 0.002).
Source: ResultsAbstract: Conclusion
Cognitive impairment was common among patients with PD, particularly those with the PIGD subtype. The PIGD subtype and lower serum irisin levels were associated with the presence of PDCI. In the joint‐category analysis, patients in the PIGD‐low‐irisin group had higher odds of concurrent cognitive impairment than those in the TD‐high‐irisin group.
Source: ConclusionAuthors’ abstract
ABSTRACT
Introduction
Cognitive impairment is a common non‐motor symptom of Parkinson's disease (PD) that markedly reduces patients’ quality of life. Given the clinical heterogeneity of PD‐related cognitive impairment (PDCI), further clarification of clinical and circulating biological factors associated with cognitive status may help improve our understanding of cognitive dysfunction in PD.
Methods
In this cross‐sectional study, 243 patients with PD and 90 age‐ and sex‐matched healthy controls (HCs) were enrolled. Cognitive function was evaluated using the Montreal Cognitive Assessment (MoCA), and patients with PD were classified into the PD with cognitive impairment (PDCI) and PD without cognitive impairment (PDNCI) groups. Based on motor symptoms, PD patients were further divided into three subtypes: tremor‐dominant (TD), postural instability and gait disorder (PIGD), and indeterminate subtype (IND). Group comparisons and logistic regression analyses were performed to examine factors associated with cognitive impairment.
Results
Serum irisin levels did not differ significantly between patients with PD and healthy controls (p = 0.478). Compared with PDNCI patients, those with PDCI had lower serum irisin levels. Among motor subtypes, the PIGD group showed a higher prevalence of cognitive impairment (68.8% vs. 46.2%, p < 0.001) and significantly lower irisin levels compared with the TD group [3.25 (2.62 to 4.14) vs. 4.12 (3.42 to 5.07) µg/mL, p < 0.001]. Serum irisin levels were weakly but positively associated with memory performance, and this association remained significant after FDR correction across the five cognitive domains (r = 0.194, FDR‐adjusted p = 0.010).
Compared with patients in the TD: high irisin group, those in the PIGD: low irisin group had higher odds of concurrent cognitive impairment (OR = 6.065, 95% CI: 2.974 to 18.638, p = 0.002).
Conclusion
Cognitive impairment was common among patients with PD, particularly those with the PIGD subtype. The PIGD subtype and lower serum irisin levels were associated with the presence of PDCI. In the joint‐category analysis, patients in the PIGD‐low‐irisin group had higher odds of concurrent cognitive impairment than those in the TD‐high‐irisin group.
Publication and source details
Original title: Correlation Between Cognitive Function and Serum Irisin Levels in Parkinson's Disease Patients
Meilin Gui; Lixia Qin; Lingling Lv; Jinduo Huang; Shenglan Hu; Kexin Chen; Xing Wang; Yiwen Zhou; Beisha Tang; Hainan Zhang; Chunyu Wang
Brain and Behavior · 2026
© 2026 The Author(s). Brain and Behavior published by Wiley Periodicals LLC.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. National Natural Science Foundation of China10.13039/501100001809 8247127782101342 National Science Foundation of Hunan Province 2024JJ5471Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T21:35:44.215575+00:00
DOI: 10.1002/brb3.71848 · PMC13686351